Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
77M
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
18.5M
-
Shares change
-
-1.84M
-
Total reported value, excl. options
-
$114M
-
Value change
-
-$22.9M
-
Put/Call ratio
-
1.39
-
Number of buys
-
48
-
Number of sells
-
-31
-
Price
-
$6.15
Significant Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q3 2018
102 filings reported holding CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value as of Q3 2018.
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.5M shares
of 77M outstanding shares and own 24.09% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.4M shares), BlackRock Inc. (1.9M shares), Vanguard Group Inc (1.26M shares), SPHERA FUNDS MANAGEMENT LTD. (1.15M shares), Rock Springs Capital Management LP (975K shares), MILLENNIUM MANAGEMENT LLC (899K shares), AWM Investment Company, Inc. (875K shares), NORTHPOINTE CAPITAL LLC (687K shares), Sofinnova Ventures Inc (607K shares), and Marshall Wace North America L.P. (583K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.